trending Market Intelligence /marketintelligence/en/news-insights/trending/O2gQJrRmCXjaiwu3I3iQfw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Israeli court orders temporary halt to Kitov Pharmaceuticals-TyrNovo deal

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Israeli court orders temporary halt to Kitov Pharmaceuticals-TyrNovo deal

Kitov Pharmaceuticals Holdings Ltd. said the Tel Aviv District Court on Jan. 19 issued a temporary interlocutory injunction, prohibiting Kitov and Goldman Hirsh Partners Ltd. to take any further steps to complete Kitov's acquisition of a 56% stake in Israel-based TyrNovo Ltd. from Goldman Hirsh, but only to such an extent that transaction had not yet closed.

The court's order is in response to a motion filed by Taoz – Company for Management and Holdings of Companies Ltd., a shareholder with a 3.12% stake in TyrNovo. Taoz is alleging certain rights as a minority shareholder in TyrNovo.

The court rejected the additional temporary interlocutory injunctive relief sought by Taoz, including changes to the composition of TyrNovo's board and Goldman Hirsh making any disposition of its holdings in TyrNovo.

Taoz is also alleging purported contractual rights with Goldman Hirsh and/or TyrNovo which are alleged to bind third parties. The alleged rights include pro rata tag-along rights over any transfer of shares by Goldman Hirsh in excess of 5% of TyrNovo's issued and outstanding share capital; and rights to prevent a sale by Goldman Hirsh of more than 14% of TyrNovo's capital.

The court ordered Taoz to deposit funds or post a bond in the amount of 100,000 Israeli shekels by not later than Jan. 22; ordered the respondents to submit responses to the motion by Jan. 23; and scheduled a hearing with respect to the motion to be held Jan. 29.

Kitov said the completed TyrNovo acquisition closed in accordance with its terms on Jan. 13, and is seeking clarification in the decision with respect to certain aspects of the injunction to the extent that it applies to the post-closing matters surrounding the acquisition.

As of Jan. 20, US$1 was equivalent to 3.80 Israeli shekels.